D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 23,928 252 World Ranking 14719 National Ranking 685

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

His primary areas of study are Breast cancer, Internal medicine, Cancer, Oncology and Germline mutation. His Breast cancer study incorporates themes from Ovarian cancer and Single-nucleotide polymorphism, Genotype. Christoph Engel combines topics linked to Gastroenterology with his work on Internal medicine.

The Cancer study combines topics in areas such as Cancer research, Gynecology and Pathology. The concepts of his Oncology study are interwoven with issues in Prospective cohort study, Cohort study and Gene mutation. His biological study deals with issues like Kidney disease, which deal with fields such as Sepsis and Septic shock.

His most cited work include:

  • Intensive insulin therapy and pentastarch resuscitation in severe sepsis. (2301 citations)
  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers (805 citations)
  • Association analysis identifies 65 new breast cancer risk loci (569 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer and Ovarian cancer. Christoph Engel works mostly in the field of Internal medicine, limiting it down to topics relating to Germline mutation and, in certain cases, MSH2, as a part of the same area of interest. Breast cancer is the subject of his research, which falls under Genetics.

His study on Oncology also encompasses disciplines like

  • Retrospective cohort study together with Cohort study and Prospective cohort study,
  • Hazard ratio, which have a strong connection to Proportional hazards model. His specific area of interest is Cancer, where Christoph Engel studies Breast disease. His Ovarian cancer study combines topics from a wide range of disciplines, such as Missense mutation, Gynecology and Genetic testing.

He most often published in these fields:

  • Internal medicine (40.41%)
  • Breast cancer (31.40%)
  • Oncology (29.94%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (40.41%)
  • Oncology (29.94%)
  • Breast cancer (31.40%)

In recent papers he was focusing on the following fields of study:

Christoph Engel mainly investigates Internal medicine, Oncology, Breast cancer, Cancer and Lynch syndrome. His Internal medicine research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism and PALB2. His research in Oncology intersects with topics in CHEK2, Germline mutation, Gene, Germline and Genetic counseling.

His Breast cancer research incorporates themes from Cohort study, Retrospective cohort study, Mutation, Obstetrics and Prospective cohort study. Christoph Engel has researched Cancer in several fields, including Intensive care medicine, Disease, Biomarker, Thrombosis and D-dimer. His work carried out in the field of Lynch syndrome brings together such families of science as Endometrial cancer and MSH6.

Between 2019 and 2021, his most popular works were:

  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (96 citations)
  • Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (68 citations)
  • Breast cancer risk genes - Association analysis in more than 113,000 women (22 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Christoph Engel mostly deals with Internal medicine, Cancer, Oncology, Breast cancer and Lynch syndrome. Internal medicine is represented through his Ovarian cancer and Family history research. His work in the fields of Ovarian cancer, such as Brca1 2 mutation, overlaps with other areas such as Contralateral breast cancer.

His work in Oncology tackles topics such as Genetic counseling which are related to areas like Genetic testing, Hormone replacement therapy and Age dependent. The various areas that Christoph Engel examines in his Breast cancer study include Odds ratio, Prospective cohort study and PALB2. His research investigates the link between Lynch syndrome and topics such as Endometrial cancer that cross with problems in Hysterectomy, Gynecological surgery and Medical prescription.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Frank M. Brunkhorst;Christoph Engel;Frank Bloos;Andreas Meier-Hellmann.
The New England Journal of Medicine (2008)

3429 Citations

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
JAMA (2017)

1156 Citations

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

Christoph Engel;Frank M. Brunkhorst;Hans-Georg Bone;Reinhard Brunkhorst.
Intensive Care Medicine (2007)

954 Citations

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Alfons Meindl;Heide Hellebrand;Constanze Wiek;Verena Erven.
Nature Genetics (2010)

737 Citations

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)

691 Citations

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

H F A Vasen;G Möslein;A Alonso;S Aretz.
Gut (2008)

685 Citations

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

Hans F.A. Vasen;Gabriele Möslein;Angel Alonso;Inge Bernstein.
Journal of Medical Genetics (2007)

683 Citations

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

Hans F A Vasen;Ignacio Blanco;Katja Aktan-Collan;Jessica P Gopie.
Gut (2013)

675 Citations

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)

547 Citations

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)

521 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christoph Engel

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 249

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 179

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 178

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 172

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 171

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 163

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 141

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 135

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 123

Jan Lubinski

Jan Lubinski

Pomeranian Medical University

Publications: 121

D. Gareth Evans

D. Gareth Evans

University of Manchester

Publications: 121

Esther M. John

Esther M. John

Stanford University

Publications: 121

Hiltrud Brauch

Hiltrud Brauch

German Cancer Research Center

Publications: 113

Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Institute Curie

Publications: 113

Wei Zheng

Wei Zheng

Vanderbilt University Medical Center

Publications: 112

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 111

Trending Scientists

Robert B. Moore

Robert B. Moore

Virginia Tech

Mallayan Palaniandavar

Mallayan Palaniandavar

Bharathidasan University

H.-J. Güntherodt

H.-J. Güntherodt

University of Basel

Anita K. Hopper

Anita K. Hopper

The Ohio State University

Gregory A. Buck

Gregory A. Buck

Virginia Commonwealth University

Alison M. Elliott

Alison M. Elliott

University of London

Connie Clabots

Connie Clabots

VA Midwest Health Care Network

Karl K. Turekian

Karl K. Turekian

Yale University

Terry Stancin

Terry Stancin

Case Western Reserve University

Andrew S.C. Rice

Andrew S.C. Rice

Imperial College London

Nancy F. Krebs

Nancy F. Krebs

University of Colorado Denver

Achille P. Caputi

Achille P. Caputi

University of Messina

I. William Zartman

I. William Zartman

Johns Hopkins University

Lin Yan

Lin Yan

California Institute of Technology

Something went wrong. Please try again later.